FDA Inspection 668686 — SmithKline Beecham Pharma GmbH & co. KG

SmithKline Beecham Pharma GmbH & co. KG — FEI 3004835618

The FDA completed an inspection of SmithKline Beecham Pharma GmbH & co. KG on May 24, 2010 in Dresden. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 24, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Dresden (Germany)